In particular, in a higher proportion of patients who developed HCC advanced fibrosis (40.4% vs. 88.2%; p < 0.001) and ≥6 substitutions in PKR-bd (15.4% vs. 41.2%; p = 0.01) was observed. The gene discussed is EIF2AK2; the disease is hepatocellular carcinoma.